AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial Launch
January 28, 2025
January 28, 2025
ST. LOUIS PARK, Minnesota, Jan. 28 [Category: Medical] -- Medical Alley posted the following news release:
* * *
AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial Launch
January 28, 2025 08:00 AM Eastern Standard Time
BOSTON-( BUSINESS WIRE )-Amplitude Vascular Systems ( AVS ), a medical device company focused on safely and effectively treating severely calcified arterial disease with its novel PULSE IVL(tm) platform, announ . . .
* * *
AVS Completes a $36M Series B Financing Ahead of IVL U.S. Commercial Launch
January 28, 2025 08:00 AM Eastern Standard Time
BOSTON-( BUSINESS WIRE )-Amplitude Vascular Systems ( AVS ), a medical device company focused on safely and effectively treating severely calcified arterial disease with its novel PULSE IVL(tm) platform, announ . . .
